About
Kenya Society of Haemotology & Oncology
The Kenya Society of Hematology and Oncology (KESHO) was founded by cancer and blood disorder experts to be a catalyst in cancer and blood disorders research, to help improve patient care and stimulate capacity building for cancer care within the region and provide cancer experts and physicians involved in the treatment of cancer with a forum to discuss ideas for purposes of improving practice and treatment outcomes.
Latest News
News
All NewsANCHOR Conference
Join the International Cancer Institute from 20th April 2022 to 23rd April 2022, in their inaugural Annual Comprehensive Hematology & Oncology review [...]
Read More
Trialect Short Term fellowships
Trialect is offering short-Term Fellowships in Travel Ready Countries. Note: Deadlines Fast Approaching Fellowship programs Download File
Read More
1st Annual Prostate Cancer Symposium
KESHO hosted its 1st Annual Prostate Cancer Symposium on Saturday, 26th March 2022 at the Four Points by Sheraton Hotel, Hurlingham, Nairobi. It [...]
Read More
March Cancer Awareness Month
March is the #ColorectalCancerAwarenessMonth #MyelomaAwarenessMonth #KidneyCancerAwarenessMonth and #InternationalWomensDay We held a Rectal and Colorectal CME in Feb We have CMEs on all [...]
Read More
Cancer Research in Kenya Symposium
Join us in the Cancer Research Symposium on Saturday 26th Feb 2022. Cancer research requires a multidisciplinary approach and we have a [...]
Read More
International Childhood Cancer Day
International Childhood Cancer Day is marked on 15th February. It is a global collaborative campaign to raise awareness about childhood cancer, and [...]
Read More
KESHO Recognition by the UICC
We appreciate recognition by the UICC for our contribution towards the global fight against cancer. We continually provide physicians with fora to [...]
Read More
World Cancer Day, 2022 #CloseTheCareGap
World Cancer Day is an international day marked on 4 February to raise awareness of cancer and to encourage its prevention, detection, [...]
Read More